Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories.

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus ...

Dengue’s rise in 2024, influenced by climate change and shifting serotypes, underscores the need for effective vaccines to ...

How it works Convidencia is a viral vector vaccine using adenovirus five. With a viral vector, there is essentially a viral particle, which is programmed not to replicate. So, what is administered ...

Nasal Spray H5N1 Avian Influenza Vaccine Developed Apr. 8, 2025 — Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian ...

GEO-CM04S1 Demonstrates Durable T Cell and Antibody Responses in Healthy and Immunocompromised Populations ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

The company will also present a poster on randomized Phase II data of TG4001 in combination with avelumab in the cervical cancer subgroup. The 2025 American Society of Clinical Oncology (ASCO), annual ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Appoints Dr. Senthil Ranganathan as Vice President, Technical Development and CMC Operations 22.04.2025 / 15:07 CET/CEST The issuer is solely ...

Intranasal influenza virus-vectored vaccine offers protection against clade 2.3.4.4b H5N1 infection in small animal models. Nature Communications , 2025; 16 (1) DOI: 10.1038/s41467-025-58504-z ...

To address the emerging H5N1 threat, the HKU and CVVT team used the influenza virus vector-based nasal spray vaccine platform to develop a nasal spray H5N1 avian influenza vaccine. Animal studies ...